Vanguard Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $183M | Buy |
11,282,152
+6,983
| +0.1% | +$114K | ﹤0.01% | 1586 |
|
|
2025
Q3 | $169M | Sell |
11,275,169
-4,026
| -0% | -$49.1K | ﹤0.01% | 1633 |
|
|
2025
Q2 | $131M | Buy |
11,279,195
+135,767
| +1% | +$1.23M | ﹤0.01% | 1712 |
|
|
2025
Q1 | $82.8M | Buy |
11,143,428
+428,540
| +4% | +$3.29M | ﹤0.01% | 1874 |
|
|
2024
Q4 | $64.2M | Buy |
10,714,888
+75,448
| +0.7% | +$416K | ﹤0.01% | 2059 |
|
|
2024
Q3 | $54.5M | Buy |
10,639,440
+412,529
| +4% | +$1.8M | ﹤0.01% | 2137 |
|
|
2024
Q2 | $37M | Sell |
10,226,911
-2,642,907
| -21% | -$8.39M | ﹤0.01% | 2265 |
|
|
2024
Q1 | $41.3M | Buy |
12,869,818
+102,134
| +0.8% | +$395K | ﹤0.01% | 2249 |
|
|
2023
Q4 | $62.6M | Buy |
12,767,684
+518,642
| +4% | +$2.37M | ﹤0.01% | 2099 |
|
|
2023
Q3 | $66.8M | Buy |
12,249,042
+196,555
| +2% | +$1.3M | ﹤0.01% | 2001 |
|
|
2023
Q2 | $80.9M | Buy |
12,052,487
+75,073
| +0.6% | +$558K | ﹤0.01% | 1964 |
|
|
2023
Q1 | $106M | Buy |
11,977,414
+183,246
| +2% | +$1.62M | ﹤0.01% | 1804 |
|
|
2022
Q4 | $90.1M | Buy |
11,794,168
+122,385
| +1% | +$952K | ﹤0.01% | 1860 |
|
|
2022
Q3 | $83.1M | Buy |
11,671,783
+95,409
| +0.8% | +$899K | ﹤0.01% | 1909 |
|
|
2022
Q2 | $93.7M | Buy |
11,576,374
+485,540
| +4% | +$4.27M | ﹤0.01% | 1864 |
|
|
2022
Q1 | $154M | Buy |
11,090,834
+59,546
| +0.5% | +$936K | ﹤0.01% | 1715 |
|
|
2021
Q4 | $310M | Buy |
11,031,288
+40,615
| +0.4% | +$1.24M | 0.01% | 1331 |
|
|
2021
Q3 | $374M | Buy |
10,990,673
+813,014
| +8% | +$29.4M | 0.01% | 1168 |
|
|
2021
Q2 | $416M | Buy |
10,177,659
+155,670
| +2% | +$6.05M | 0.01% | 1109 |
|
|
2021
Q1 | $403M | Buy |
10,021,989
+366,564
| +4% | +$19.8M | 0.01% | 1087 |
|
|
2020
Q4 | $571M | Buy |
9,655,425
+2,589,318
| +37% | +$134M | 0.02% | 810 |
|
|
2020
Q3 | $344M | Buy |
7,066,107
+1,424,673
| +25% | +$59.9M | 0.01% | 949 |
|
|
2020
Q2 | $273M | Buy |
5,641,434
+1,169,653
| +26% | +$42.6M | 0.01% | 1080 |
|
|
2020
Q1 | $124M | Buy |
4,471,781
+2,890,710
| +183% | +$80.6M | 0.01% | 1400 |
|
|
2019
Q4 | $47.3M | Buy |
1,581,071
+84,685
| +6% | +$2.43M | ﹤0.01% | 2134 |
|
|
2019
Q3 | $46.2M | Buy |
1,496,386
+1,296,386
| +648% | +$52.9M | ﹤0.01% | 2108 |
|
|
2019
Q2 | $9.66M | Buy |
+200,000
| New | +$8.86M | ﹤0.01% | 2880 |
|
Other funds holding ADPT
DCM